
|Videos|February 22, 2023
Advice to Patients with Multiple Myeloma Facing Hospital Admission For Teclistamab Therapy
Anne-Marie Jacob shares advice for patients with multiple myeloma receiving teclistamab who are recommended for hospital admission for CRS risk.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Palbociclib Combo in HR+, HER2+ Metastatic Breast Cancer
2
NCCN Updates Bladder Cancer Guidelines for ctDNA MRD Testing
3
Sacituzumab Govitecan Receives FDA Approval Across 2 TNBC Indications
4
Zanzalintinib/Atezolizumab Misses Survival End Point in Non-MSI-H mCRC Subgroup
5

























































































